chr1-54999208-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_057176.3(BSND):c.22C>T(p.Arg8Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R8L) has been classified as Pathogenic.
Frequency
Consequence
NM_057176.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BSND | NM_057176.3 | c.22C>T | p.Arg8Trp | missense_variant | 1/4 | ENST00000651561.1 | NP_476517.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BSND | ENST00000651561.1 | c.22C>T | p.Arg8Trp | missense_variant | 1/4 | NM_057176.3 | ENSP00000498282 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251414Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135896
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461838Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727226
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74470
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 10, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 8 of the BSND protein (p.Arg8Trp). This variant is present in population databases (rs74315285, gnomAD 0.06%). This missense change has been observed in individuals with Bartter syndrome with sensorineural deafness (PMID: 11687798, 29254190, 35709690). ClinVar contains an entry for this variant (Variation ID: 4381). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BSND protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects BSND function (PMID: 18776122). This variant disrupts the p.Arg8 amino acid residue in BSND. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29986705, 30174009). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 13, 2023 | Published functional studies demonstrate this variant renders the CIC-K channel inactive (Janssen et al., 2009); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28012523, 35709690, 36314956, 29254190, 11687798, 18776122) - |
Bartter syndrome Pathogenic:2
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 07, 2022 | Variant summary: BSND c.22C>T (p.Arg8Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251414 control chromosomes. c.22C>T has been reported in the literature as a homozygous genotype in individuals with clinically diagnosed Bartter Syndrome, Type 4a (example:Birkenhger_2001 and Wang_2017 etc.). These data indicate that the variant is likely to be associated with disease. Several publications reports experimental evidence evaluating an impact on protein function demonstrating that this variant nearly abolishes CIS -K1 activation ans is not capable of switching human CIC-K channels to an active conformation (example: Janssen_2009 and Waldegger_2002 etc.) . Another variant at the same locus p.R8L has also been shown to have similar effect (Waldegger_2002) and multiple other variants affecting the same codon have been reported in association with Bartter syndrome (p.R8G, p.R8L). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Bartter disease type 4A Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2001 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at